Medicine Stock Based on Data Mining: Returns up to 43.08% in 3 Months

Medicine Stock

The Medicine Stocks Package is designed for investors and analysts who need predictions for the best stocks to buy in the Medicine Industry. It includes 20 stocks with bullish and bearish signals and indicates the best medicine stocks to trade:

  • Top 10 Medicine stocks for the long position
  • Top 10 Medicine stocks for the short position

Package Name: Medicine Stocks
Recommended Positions: Long
Forecast Length: 3 Months (03/19/2017 – 06/19/2017)
I Know First Average: 14.59%
Medicine Stock

I Know First’s State of the Art Algorithm accurately forecasted 7 out of 10 trades in this Medicine Stocks Package for the 3 Months time period. The greatest return came from ALNY at 43.08%. IMGN and NVO also performed well for this time horizon with returns of 37.15% and 31.02%, respectively. The package itself saw an overall return of 14.59%, providing investors with a 11.43% premium above the S&P 500’s return of 3.16% for the same time period.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. Its pipeline of investigational RNAi therapeutics is focused on genetic medicines, cardio-metabolic diseases, and hepatic infectious diseases.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.